NICE

MIB132 Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease

5 technologies are described, all designed as point-of-care or home-use faecal calprotectin tests for monitoring inflammatory bowel disease (IBD). The technologies provide rapid results and help reduce hospital visits and time consuming lab tests. The technologies described are: IBDoc (Buhlmann), Quantum Blue (Buhlmann), Calprosmart Home (Calpro), Calprosmart Office (Calpro) and Calfast (Eurospital).

NICE website: https://www.nice.org.uk/advice/mib132